The Role of Adiponectin in Obesity, Diabetes, and Cardiovascular Disease
- 20 February 2009
- journal article
- review article
- Published by Wiley in Journal of the CardioMetabolic Syndrome
- Vol. 4 (1), 44-49
- https://doi.org/10.1111/j.1559-4572.2008.00030.x
Abstract
Nearly 1 in 4 adults in the United States is obese. The connection between obesity and insulin resistance, type 2 diabetes, and cardiovascular disease is a well researched one. The increasing prevalence of each of these diseases has become a growing concern for the medical community. Adiponectin is a collagen-like plasma protein secreted by adipocytes that has been suggested to play a causal role in the development of insulin resistance and cardiovascular disease. The protein has been found to be decreased in cases of insulin resistance, diabetes, atherosclerosis, and coronary artery disease. Up-regulation of adiponectin and its receptor, through the use of thiazolidinediones, has been found to be partially related to insulin sensitization and thus antidiabetic effects. In this review, we discuss adiponectin's antiatherogenic effects, its association with insulin resistance and obesity, and the possibility of using adiponectin and its receptor as a therapeutic target.Keywords
This publication has 43 references indexed in Scilit:
- Selective Downregulation of the High–Molecular Weight Form of Adiponectin in Hyperinsulinemia and in Type 2 DiabetesDiabetes, 2007
- Adipokines and Risk of Type 2 Diabetes in Older MenDiabetes Care, 2007
- Associations of Adiponectin Levels With Incident Impaired Glucose Metabolism and Type 2 Diabetes in Older Men and WomenDiabetes Care, 2006
- Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndromeJCI Insight, 2006
- Do low levels of circulating adiponectin represent a biomarker or just another risk factor for the metabolic syndrome?Diabetes, Obesity and Metabolism, 2006
- Anti-inflammatory and metabolic effects of candesartan in hypertensive patientsInternational Journal of Cardiology, 2006
- Mice Lacking Adiponectin Show Decreased Hepatic Insulin Sensitivity and Reduced Responsiveness to Peroxisome Proliferator-activated Receptor γ AgonistsOnline Journal of Public Health Informatics, 2006
- Additive Beneficial Effects of Losartan Combined With Simvastatin in the Treatment of Hypercholesterolemic, Hypertensive PatientsCirculation, 2004
- Association of Hypoadiponectinemia With Impaired VasoreactivityHypertension, 2003
- Cloning of adiponectin receptors that mediate antidiabetic metabolic effectsNature, 2003